Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of Cellular Biochemistry
|
October 17, 2018
MicroRNA-328 ameliorates oxidized low-density lipoprotein-induced endothelial cells injury through targeting HMGB1 in atherosclerosis
Chun-Yang Wu, Zhao-Feng Zhou, Bin Wang, et al.
Molecular Biology Reports
|
November 7, 2025
A new KLF13 loss-of-function mutation responsible for sporadic dilated cardiomyopathy
Xiang Tang, Yin Wang, Chen-Xi Yang, et al.
Oncotarget
|
December 20, 2018
IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI
Hai-Lun Li, Zhuan Yan, Zun-Ping Ke, et al.
Diagnostics (Basel, Switzerland)
|
January 10, 2026
Discovery of <i>SOX5</i> as a New Causative Gene for Atrial Fibrillation
Dao-Liang Zhang, Xing-Biao Qiu, Ning Li, et al.
Diagnostics (Basel, Switzerland)
|
August 28, 2025
Discovery of <i>ETS1</i> as a New Gene Predisposing to Dilated Cardiomyopathy
Zun-Ping Ke, Jia-Ning Gu, Chen-Xi Yang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
September 29, 2009
[The role of PEP-1-SOD1 fusion protein on ischemia-reperfusion injury in isolated perfused rat hearts.]
Zun-Ping Ke, Jia-Ning Wang, Jun-Ming Tang, et al.
Genetics and Molecular Biology
|
April 4, 2022
A novel PRRX1 loss-of-function variation contributing to familial atrial fibrillation and congenital patent ductus arteriosus
Zun-Ping Ke, Gao-Feng Zhang, Yu-Han Guo, et al.
Oncotarget
|
May 4, 2017
Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia/reperfusion injury by inhibiting cell apoptosis and inflammation
Yong Xu, Bo Zhang, Da Xie, et al.
Journal of the American Heart Association
|
November 30, 2021
PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation
Xiao-Juan Guo, Xing-Biao Qiu, Jun Wang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of Cellular Biochemistry
|
October 17, 2018
MicroRNA-328 ameliorates oxidized low-density lipoprotein-induced endothelial cells injury through targeting HMGB1 in atherosclerosis
Chun-Yang Wu, Zhao-Feng Zhou, Bin Wang, et al.
Molecular Biology Reports
|
November 7, 2025
A new KLF13 loss-of-function mutation responsible for sporadic dilated cardiomyopathy
Xiang Tang, Yin Wang, Chen-Xi Yang, et al.
Oncotarget
|
December 20, 2018
IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI
Hai-Lun Li, Zhuan Yan, Zun-Ping Ke, et al.
Diagnostics (Basel, Switzerland)
|
January 10, 2026
Discovery of <i>SOX5</i> as a New Causative Gene for Atrial Fibrillation
Dao-Liang Zhang, Xing-Biao Qiu, Ning Li, et al.
Diagnostics (Basel, Switzerland)
|
August 28, 2025
Discovery of <i>ETS1</i> as a New Gene Predisposing to Dilated Cardiomyopathy
Zun-Ping Ke, Jia-Ning Gu, Chen-Xi Yang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
September 29, 2009
[The role of PEP-1-SOD1 fusion protein on ischemia-reperfusion injury in isolated perfused rat hearts.]
Zun-Ping Ke, Jia-Ning Wang, Jun-Ming Tang, et al.
Genetics and Molecular Biology
|
April 4, 2022
A novel PRRX1 loss-of-function variation contributing to familial atrial fibrillation and congenital patent ductus arteriosus
Zun-Ping Ke, Gao-Feng Zhang, Yu-Han Guo, et al.
Oncotarget
|
May 4, 2017
Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia/reperfusion injury by inhibiting cell apoptosis and inflammation
Yong Xu, Bo Zhang, Da Xie, et al.
Journal of the American Heart Association
|
November 30, 2021
PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation
Xiao-Juan Guo, Xing-Biao Qiu, Jun Wang, et al.
Page
of 3